Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC).

Trial Profile

Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC).

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2014

At a glance

  • Drugs Ethinylestradiol/etonogestrel (Primary) ; Oral contraceptives
  • Indications Pregnancy
  • Focus Adverse reactions
  • Acronyms TASC
  • Most Recent Events

    • 08 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 02 Nov 2011 Planned end date changed from 1 Sep 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
    • 12 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top